相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa
Maria Fernanda Mojica et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Activity of fosfomycin when tested against US contemporary bacterial isolates
Robert K. Flamm et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance
Bongiorno Dafne et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Emergence of two novel sequence types (3366 and 3367) NDM-1-and OXA-48-co-producing K. pneumoniae in Italy
Floriana Gona et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia
Carlota Gudiol et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
In vitro activity of fosfomycin trometamol and other oral antibiotics against multidrug-resistant uropathogens
Maria Lina Mezzatesta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Fosfomycin: Resurgence of an old companion
Sangeeta Sastry et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Revival of old antibiotics: structuring the re-development process to optimize usage
U. Theuretzbacher et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Epidemiology of Staphylococcus aureus in Italy: First nationwide survey, 2012
Floriana Campanile et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2015)
Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing Methods
L. V. Perdigao-Neto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
The revival of fosfomycin
Argyris S. Michalopoulos et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2010)
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies
Matthew E. Falagas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Determination of minimum inhibitory concentrations
JM Andrews
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
分享论文
